WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
WuXi AppTec and its affiliates faced volatile trading after the introduction of a revised version of the Biosecure Act by U.S. lawmakers that gives U.S. companies time until 2032, after which business tie-ups with the named Chinese biotech firms would be restricted.
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
